← Back to Search

Corticosteroid

Dexamethasone for Distal Radius Fracture

Q: What is the uppermost limit of participants for this experiment?

Affirmative. According to clinicaltrials.gov, this medical experiment is recruiting participants and was first listed on July 10th 2021 with the last update taking place on July 14th 2022. It requires 75 individuals from a single site for enrolment.

Q: For what ailments is Dexamethasone generally prescribed?

Dexamethasone is a viable therapeutic option for ophthalmic, sympathetic and retinal vein occlusions that affect the eye branches.

Q: Are additional participants being sought for this investigation?

As indicated on clinicaltrials.gov, this research trial is actively recruiting participants. The post was initially posted on July 10th 2021 and has seen the most recent update occur on July 14th 2022.

Q: Has there been any other research conducted on the efficacy of Dexamethasone?

Currently, 552 medical studies are being conducted on Dexamethasone; 143 of these experiments have entered Phase 3. The vast majority of trials for this drug are hosted in Elk Grove Village, <a href="https://www.withpower.com/clinical-trials/illinois">Illinois</a> yet there is an extensive network spanning 18657 locations across the nation.

Phase < 1

Waitlist Available

Research Sponsored by Northwell Health

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 48 hours, 1 week, 2 weeks

Awards & highlights

Study Summary

This trial is looking at whether using dexamethasone during surgery can help with pain and stiffness after surgery for a broken radius bone.

Eligible Conditions

Distal Radius Fracture

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 48 hours, 1 week, 2 weeks

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~48 hours, 1 week, 2 weeks

This trial's timeline: 3 weeks for screening, Varies for treatment, and 48 hours, 1 week, 2 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Patient rated wrist evaluation

Secondary outcome measures

Finger-to-palm distance

Total opioid consumption

Visual analog scale

Side effects data

From 2013 Phase 4 trial • 122 Patients • NCT01474915

Deep Vein Thrombosis

Cerebrospinal fluid leak

Fever

100%

80%

60%

40%

20%

Study treatment Arm

Ondansetron

Aprepitant

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: DexamethasoneExperimental Treatment1 Intervention

Patient will receive intraoperative dexamethasone during distal radius open reduction and internal fixation

Group II: No dexamethasonePlacebo Group1 Intervention

Patient will not receive intraoperative dexamethasone during distal radius open reduction and internal fixation

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Dexamethasone

2007

Completed Phase 4

~2590

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Northwell HealthLead Sponsor

458 Previous Clinical Trials

470,863 Total Patients Enrolled

Media Library

Dexamethasone (Corticosteroid) Clinical Trial Eligibility Overview. Trial Name: NCT04889547 — Phase < 1

Distal Radius Fracture Research Study Groups: No dexamethasone, Dexamethasone

Distal Radius Fracture Clinical Trial 2023: Dexamethasone Highlights & Side Effects. Trial Name: NCT04889547 — Phase < 1

Dexamethasone (Corticosteroid) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04889547 — Phase < 1

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the uppermost limit of participants for this experiment?

"Affirmative. According to clinicaltrials.gov, this medical experiment is recruiting participants and was first listed on July 10th 2021 with the last update taking place on July 14th 2022. It requires 75 individuals from a single site for enrolment."

Answered by AI

For what ailments is Dexamethasone generally prescribed?

"Dexamethasone is a viable therapeutic option for ophthalmic, sympathetic and retinal vein occlusions that affect the eye branches."

Answered by AI

Are additional participants being sought for this investigation?

"As indicated on clinicaltrials.gov, this research trial is actively recruiting participants. The post was initially posted on July 10th 2021 and has seen the most recent update occur on July 14th 2022."

Answered by AI

Has there been any other research conducted on the efficacy of Dexamethasone?

"Currently, 552 medical studies are being conducted on Dexamethasone; 143 of these experiments have entered Phase 3. The vast majority of trials for this drug are hosted in Elk Grove Village, Illinois yet there is an extensive network spanning 18657 locations across the nation."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Randomized Controlled Trial Assessing the Effect of Dexamethasone on Postoperative Function After Distal Radius Fixation

2021. "Randomized Controlled Trial Assessing the Effect of Dexamethasone on Postoperative Function After Distal Radius Fixation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04889547.